Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study

Terlipressin with albumin, the recommended treatment for hepatorenal syndrome-acute kidney injury (HRS-AKI), is associated with adverse events. Furthermore, the course of AKI in patients with acute-on-chronic liver failure (ACLF) is unknown. We aimed to analyze the safety and efficacy of terlipressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulkarni, Anand V., Ravikumar, Sowmya Tirumalige, Tevethia, Harshvardhan, Premkumar, Madhumita, Kumar, Karan, Sharma, Mithun, Gupta, Rajesh, Rao, Padaki Nagaraja, Reddy, Duvvuru Nageshwar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976022/
https://www.ncbi.nlm.nih.gov/pubmed/35365736
http://dx.doi.org/10.1038/s41598-022-09505-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976022/
https://www.ncbi.nlm.nih.gov/pubmed/35365736
http://dx.doi.org/10.1038/s41598-022-09505-1

Ejemplares similares